Biotech news for Wednesday, May 20, 2026, ranked by our 5-dimension investment framework — regulatory, technology, commercial, manufacturing, and narrative.
Relay Therapeutics ( RLAY ) shares gained on Tuesday after initial data from a mid-stage trial for its lead asset, zovegalisib, which TD Cowen called “a home run” against vascular anomalies, a group of rare disorders caused by abnormal development of vascular…
Earnings Call Insights: Gossamer Bio (GOSS) Q1 2026 Management View CEO Faheem Hasnain framed PROSERA’s topline as clinically meaningful but statistically mixed: "PROSERA showed a clinically meaningful placebo-adjusted improvement of 13.3 meters in 6-minute wa…
Renaissance Technologies returned -4.58% in Q1 2026, slightly outperforming the broader S&P 500 index, which declined 4.63% during the quarter, according to available performance data. The quantitative hedge fund later disclosed its latest Q1 2026 holdings…
HHS said it is rescinding the charter of the CDC's Advisory Committee on Immunization Practices "due to an administrative error in meeting the revised public notification timing requirements under the revised Federal Advisory Committee Act," per a posting in t…
BioMarin Pharmaceutical ( BMRN ) said that BMN 401, an enzyme therapy for the rare disease ENPP1 deficiency, only hit one of two primary endpoints in a phase 3 trial. Results showed that children treated with BMN 401 saw statistically significant increases in
Quantum Cyber N.V. ( QUCY ) said on Monday it formed Quantum Drones Corporation, a wholly owned Nevada-based subsidiary focused on pursuing U.S. government opportunities in autonomous drone warfare, counter-UAS and border security technologies. Stock up +11% i…
Quince Therapeutics ( QNCX ) on Monday said it has acquired Orphai Therapeutics, a clinical-stage biotechnology company. The acquisition brings Orphai’s lead program, LAM-001, an inhaled formulation of rapamycin (mTOR inhibitor), to treat rare pulmonary diseas…
Stock futures were mixed on Monday as market participants closely watched worsening diplomatic and military frictions between Washington and Tehran. Here are some of Monday's biggest stock movers: Biggest stock gainers LiveRamp ( RAMP ) +27% - Shares surged af…
Kyverna Therapeutics ( KYTX ) said on Monday it appointed Greg Martini as chief financial officer as the company prepares for a potential commercial launch of its autoimmune disease cell therapy candidate miv-cel. Martini joins Kyverna from Ironwood Pharmaceut…
Jacob Wackerhausen/iStock via Getty Images United Therapeutics ( UTHR ) Sunday said that its investigational drug ralinepag cut the risk of clinical worsening by 55% compared with placebo in patients with pulmonary arterial hypertension, meeting the primary en…
Quant rankings for the upcoming earnings calendar show strength concentrated across consumer discretionary, communication services, and financials, while weakness is more pronounced in information technology and select consumer-facing segments. A total of 215…
Eoneren ImmunityBio ( IBRX ) on Saturday announced a licensing deal to acquire exclusive U.S. rights to a bladder cancer therapy called Bacillus Calmette-Guerin (BCG) treatment from Japan BCG Laboratory, a Japanese drug developer. Under the agreement, the San…